P
Peipei Liu
Researcher at Chinese Center for Disease Control and Prevention
Publications - 32
Citations - 3081
Peipei Liu is an academic researcher from Chinese Center for Disease Control and Prevention. The author has contributed to research in topics: Medicine & Biology. The author has an hindex of 7, co-authored 19 publications receiving 1633 citations.
Papers
More filters
Journal ArticleDOI
Susceptibility of ferrets, cats, dogs, and other domesticated animals to SARS-coronavirus 2.
Jianzhong Shi,Zhiyuan Wen,Gongxun Zhong,Huanliang Yang,Chong Wang,Baoying Huang,Renqiang Liu,Xijun He,Lei Shuai,Ziruo Sun,Yubo Zhao,Peipei Liu,Libin Liang,Pengfei Cui,Jinliang Wang,Xianfeng Zhang,Yuntao Guan,Wenjie Tan,Guizhen Wu,Hualan Chen,Zhigao Bu +20 more
TL;DR: It is found that SARS-CoV-2 replicates poorly in dogs, pigs, chickens, and ducks, but ferrets and cats are permissive to infection and Additionally, cats are susceptible to airborne transmission.
Journal ArticleDOI
Safety and immunogenicity of an inactivated SARS-CoV-2 vaccine, BBIBP-CorV: a randomised, double-blind, placebo-controlled, phase 1/2 trial.
Shengli Xia,Yuntao Zhang,Y. Wang,Hui Wang,Yunkai Yang,George F. Gao,Wenjie Tan,Guizhen Wu,Miao Xu,Zhiyong Lou,Weijin Huang,Wenbo Xu,Baoying Huang,Huijuan Wang,Wei Wang,Wei Zhang,Na Li,Zhiqiang Xie,Ling Ding,Wangyang You,Yuxiu Zhao,Xuqin Yang,Yang Liu,Qian Wang,Lili Huang,Yongli Yang,Guangxue Xu,Bojian Luo,Wenling Wang,Peipei Liu,Wanshen Guo,Xiaoming Yang +31 more
TL;DR: The primary outcomes were safety and tolerability and immunogenicity, assessed as the neutralising antibody responses against infectious SARS-CoV-2, and no serious adverse event was reported within 28 days post vaccination.
Journal ArticleDOI
Age-related rhesus macaque models of COVID-19
Pin Yu,Feifei Qi,Yanfeng Xu,Fengdi Li,Peipei Liu,Jiayi Liu,Linlin Bao,Wei Deng,Hong Gao,Zhiguang Xiang,Chong Xiao,Qi Lv,Shuran Gong,Jiangning Liu,Zhiqi Song,Yajin Qu,Jing Xue,Qiang Wei,Mingya Liu,Guanpeng Wang,Shunyi Wang,Haisheng Yu,Xing Liu,Baoying Huang,Wenling Wang,Li Zhao,Huijuan Wang,Fei Ye,Weimin Zhou,Wei Zhen,Jun Han,Guizhen Wu,Qi Jin,Jianwei Wang,Wenjie Tan,Chuan Qin +35 more
TL;DR: Since December 2019, an outbreak of the Corona Virus disease 2019 (COVID‐19) caused by severe acute respiratory syndrome coronavirus (SARS‐CoV‐2) in Wuhan, China, has become a public health emergency of international concern.
Journal ArticleDOI
Cold-chain transportation in the frozen food industry may have caused a recurrence of COVID-19 cases in destination: Successful isolation of SARS-CoV-2 virus from the imported frozen cod package surface.
Peipei Liu,Mengjie Yang,Xiang Zhao,Yuanyuan Guo,Liang Wang,Jing Zhang,Wenwen Lei,Weifang Han,Fachun Jiang,William J. Liu,George F. Gao,George F. Gao,Guizhen Wu +12 more
TL;DR: This is the first time worldwide, Sars-CoV-2 were isolated from the imported frozen cod outer package's surface, which showed that imported frozen food industry could import SARS-Cov-2 virus.
Journal ArticleDOI
Safety and immunogenicity of an inactivated COVID-19 vaccine, BBIBP-CorV, in people younger than 18 years: a randomised, double-blind, controlled, phase 1/2 trial.
Isakova A'lo Anvarjonovna,Shengli Xia,Yuntao Zhang,Y. Wang,Hui Wang,Yunkai Yang,George F. Gao,Wenjie Tan,Guizhen Wu,Miao Xu,Zhiyong Lou,Weijin Huang,Wenbo Xu,Baoying Huang,Wei Wang,Wei Zhang,Na Li,Zhiqiang Xie,Xiujuan Zhu,Ling Ding,Wangyang You,Yuxiu Zhao,Jun Zhao,Lili Huang,Xuezhong Shi,Yongli Yang,Guangxue Xu,Wenling Wang,Peipei Liu,Meng Ma,YuLing Qiao,SuHua Zhao,JingJing Chai,Qinqin Li,Hui Fu,Ying Xu,XiaoTong Zheng,Wanshen Guo,Xiaoming Yang +38 more
TL;DR: Wang et al. as mentioned in this paper assessed the safety and immunogenicity of BBIBP-CorV in participants aged 3-17 years, using a randomized, double-blind, controlled, phase 1/2 trial at Shangqiu City Liangyuan District Center for Disease Control and Prevention in Henan, China.